Brainstorm Cell Therapeutics Inc. (BCLI)
OTCMKTS · Delayed Price · Currency is USD
0.8645
+0.0145 (1.71%)
At close: Jun 18, 2026
Brainstorm Cell Therapeutics Employees
Brainstorm Cell Therapeutics had 20 employees as of December 31, 2025. The number of employees decreased by 7 or -25.93% compared to the previous year.
Employees
20
Change
-7
Growth
-25.93%
Revenue / Employee
n/a
Profits / Employee
-$515,350
Market Cap
9.54M
Employees Chart
Employees History
Brainstorm Cell Therapeutics News
- 18 days ago - BrainStorm Cell Therapeutics Announces Publication Calling for Updated FDA Approaches to ALS, Rare Diseases and Regenerative Medicine - PRNewsWire
- 23 days ago - Lunai Bioworks and BrainStorm launch foundation for neurological diseases - TheFly
- 23 days ago - BrainStorm Cell Therapeutics Appoints Former FDA Associate Commissioner Peter J. Pitts to Board of Directors - PRNewsWire
- 4 weeks ago - Brainstorm Cell Therapeutics Registration statement: Registration filing - Filings
- 4 weeks ago - BrainStorm Cell Therapeutics Announces Aggregate of $400,000 in Private Placements Priced at Premium to Market - PRNewsWire
- 5 weeks ago - BrainStorm Cell Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update - PRNewsWire
- 5 weeks ago - Brainstorm Cell Therapeutics Quarterly report: Q1 2026 - Filings
- 5 weeks ago - Brainstorm Cell Therapeutics Earnings release: Q1 2026 - Filings